Gene · 8784
Papers4,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 4,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| speedingCARs: accelerating the engineering of CAR T cells by signaling domain shuffling and single-cell sequencing. | Nat Commun | 2022 | 36323661 | PubTator, text mining | PubMed |
| Comprehensive Molecular Analyses of an SLC Family-Based Model in Stomach Adenocarcinoma. | Pathol Oncol Res | 2022 | 36313898 | PubTator, text mining | PubMed |
| The development of a novel signature based on the m6A RNA methylation regulator-related ceRNA network to predict prognosis and therapy response in sarcomas. | Front Genet | 2022 | 36313417 | PubTator, text mining | PubMed |
| Two novel lncRNAs AF111167.2 and AL162377.1 targeting miR-21-5p mediated down expression of SYDE2 correlates with poor prognosis and tumor immune infiltration of ccRCC. | Heliyon | 2022 | 36311369 | PubTator, text mining | PubMed |
| Residual persistence of cytotoxicity lymphocytes and regulatory T cells in patients with severe coronavirus disease 2019 over a 1-year recovery process. | Acute Med Surg | 2022 | 36311179 | PubTator, text mining | PubMed |
| Characterization of spleen and lymph node cell types via CITE-seq and machine learning methods. | Front Mol Neurosci | 2022 | 36311013 | PubTator, text mining | PubMed |
| LPCAT1 acts as an independent prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma. | Eur J Med Res | 2022 | 36307879 | PubTator, text mining | PubMed |
| Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy. | Cancer Cell | 2022 | 36306792 | PubTator, text mining | PubMed |
| Quiescent innate and adaptive immune responses maintain the long-term integrity of corneal endothelium reconstituted through allogeneic cell injection therapy. | Sci Rep | 2022 | 36302875 | PubTator, text mining | PubMed |
| Regulation of autophagy fires up the cold tumor microenvironment to improve cancer immunotherapy. | Front Immunol | 2022 | 36300110 | PubTator, text mining | PubMed |
| Prognostic significance and identification of basement membrane-associated lncRNA in bladder cancer. | Front Oncol | 2022 | 36300088 | PubTator, text mining | PubMed |
| Unraveling the Potential Role of NEDD4-like E3 Ligases in Cancer. | Int J Mol Sci | 2022 | 36293239 | PubTator, text mining | PubMed |
A Case Report on Longitudinal Collection of Tumour Biopsies for Gene Expression-Based Tumour Microenvironment Analysis from Pancreatic Cancer Patients Treated with Endoscopic Ultrasound Guided Radiofrequency Ablation. | Curr Oncol | 2022 | 36290808 | PubTator, text mining | PubMed |
| Comprehensive machine-learning survival framework develops a consensus model in large-scale multicenter cohorts for pancreatic cancer. | Elife | 2022 | 36282174 | PubTator, text mining | PubMed |
| T cell dysregulation in inflammatory diseases in ICU. | Intensive Care Med Exp | 2022 | 36279072 | PubTator, text mining | PubMed |
| Deficiency of C-reactive protein or human C-reactive protein transgenic treatment aggravates influenza A infection in mice. | Front Immunol | 2022 | 36275680 | PubTator, text mining | PubMed |
| A novel angiogenesis-based molecular signature related to prognosis and tumor immune interactions of pancreatic cancer. | Front Cell Dev Biol | 2022 | 36274838 | PubTator, text mining | PubMed |
| CMTM4 is a subunit of the IL-17 receptor and mediates autoimmune pathology. | Nat Immunol | 2022 | 36271145 | PubTator, text mining | PubMed |
| A novel necroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma. | Front Genet | 2022 | 36267408 | PubTator, text mining | PubMed |
| Patients With Severe Multiple Sclerosis Exhibit Functionally Altered CD8+ Regulatory T Cells. | Neurol Neuroimmunol Neuroinflamm | 2022 | 36266052 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8784/papers?page=45